Clinical trial

Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease

NCT01001637

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-10-01

PhaseNA

Study timeline

Study start (unknown)2009-10-01Date precision: month

Registry last updated2023-09-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

Curcumin FormulationDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Jaslok Hospital and Research Centrelead sponsor

Pharmanza Herbal Pvt Ltdcollaborator

Verdure Sciencescollaborator

University of California, Los Angelescollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01001637 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.